Diamond BioFund is the largest fund dedicated to biotechnology innovation, managing assets worth over 260 million USD. We are also the first evergreen fund in Taiwan, assisting our venture partners to grow continuously. With renowned shareholders including a Fortune 500 enterprise and major financial holding companies in Taiwan, Diamond BioFund is led by an experienced management team with professionals from various backgrounds such as biotech, financial services, and academia, supporting our venture partners with practical knowledge in development and management. Driven by innovation excellence and operation efficiency, Diamond BioFund is committed to becoming the leading biotech venture fund in Taiwan and the global community.

Diamond BioFund currently focuses on healthcare and biotech related industry, including new drugs development, medical devices, health supplements, diagnostics, healthcare retailing channels, and innovative healthcare services. Our investment targets early stage innovative technology with global cutting edge impact. Leveraging the boom in China’s healthcare market, we also target valuable assets in the Greater China region.

Diamond BioFund Inc.

RA Capital is an established biotech venture capital firm known for its active investments in the life science sector.

RA Capital

Orbimed is a prominent venture capital firm specializing in the healthcare and biotechnology sectors, with a focus on early-stage investments.

Orbimed

ARCH Venture Partners is a leading venture capital firm that focuses on early-stage investments in biotechnology and healthcare companies.

ARCH Venture Partners

Versant Ventures is a well-known venture capital firm with a strong focus on investing in innovative biotechnology and healthcare companies.

Versant Ventures

Pacific Biosciences is a leading life science technology company known for its innovative solutions in the biotechnology sector.

Pacific Biosciences

Frazier Healthcare Partners is a venture capital firm focused on investing in innovative healthcare and life science companies.

Frazier Healthcare Partners

Diamond Biofund is a venture capital firm that specializes in investing in early-stage life science companies. The firm focuses on providing capital and strategic support to innovative startups in the biotechnology, pharmaceuticals, and healthcare sectors.

Diamond Biofund

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jun 22, 2024 8:51 AM	76ef456d
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jun 22, 2024 2:20 PM	b1448a90
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Jun 22, 2024 8:51 AM	b7179c8b
translate crunchbase fundingrounds	general
peers	general
news basic	general	Jun 22, 2024 8:51 AM	1b5725f2
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:DIAMONDBIOFUND

Diamond Biofund